Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - carbamazepinum inn - tafla - 200 mg

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - carbamazepinum inn - forðatafla - 200 mg

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - carbamazepinum inn - forðatafla - 400 mg

Europäische Union - Isländisch - EMA (European Medicines Agency)

amgen europe b.v. - panitumumab - litlaræxli - Æxlishemjandi lyf - vectibix is indicated for the treatment of adult patients with wild-type ras metastatic colorectal cancer (mcrc): , in first-line in combination with folfox or folfiri. , í öðru-línu í ásamt folfiri fyrir sjúklinga sem hafa fengið fyrsta lína fluoropyrimidine byggir lyfjameðferð (án irínótecan). , eitt og sér eftir bilun fluoropyrimidine-, oxaliplatin-og irínótecan-inniheldur lyfjameðferð meðferð.

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

medac gesellschaft für klinische spezialpräparate gmbh - bcg bacteria - duft og leysir fyrir þvagblöðrudreifu

Europäische Union - Isländisch - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - kyrningahvítblæði, mergbólga - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - lymecyclinum inn - hart hylki - 300 mg

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml

Europäische Union - Isländisch - EMA (European Medicines Agency)

ceva santé animale - gi - hár-loft þvagræsilyf, súlfónamíð, látlaus - hundar - fyrir meðferð klínískum merki tengjast hjartabilun í hunda, þar á meðal í lungum bjúg.

Europäische Union - Isländisch - EMA (European Medicines Agency)

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - sýklalyf fyrir almenn nota, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum. viðeigandi að nota af sýklalyfjum.